“A study from Japan found that for every 10% increase in quadriceps strength relative to body weight, a person's risk of dying from any cause dropped by 23%.”
Plain restatementA Japanese study reported that higher quadriceps strength measured as a percentage of body weight was associated with lower all-cause mortality, with roughly 23% lower risk per 10-percentage-point increment in that ratio.
This claim comes from a real study, but the framing is misleading. The source is a 2015 Japanese paper in The American Journal of Medicine by Kamiya and colleagues, which followed 1,314 patients hospitalized for coronary artery disease, average age 65 and 80% male, for about five years. In that group, each 10 percentage point increase in quadriceps strength measured as a share of body weight was linked to 23% lower risk of death from any cause. The problem is that the viral version drops the population. This was a finding in heart disease patients, not in the general public, and it measured strength once at the start rather than testing whether getting stronger extends life. Weak legs in cardiac patients can also be a sign of more advanced illness and frailty, so the association may partly reflect existing disease rather than the muscle itself. Leg strength is genuinely associated with better survival across many studies, but the specific 23% number should not be read as a promise that a 10% strength gain cuts your death risk by nearly a quarter.
A study [drifted from the evidence:] from Japan found that [drifted from the evidence:] for every 10% increase in quadriceps strength [drifted from the evidence:] relative to body weight, a [drifted from the evidence:] person's risk of [drifted from the evidence:] dying from any cause dropped by 23%.
A [added by the neutral restatement:] Japanese study [added by the neutral restatement:] reported that [added by the neutral restatement:] higher quadriceps strength [added by the neutral restatement:] measured as a [added by the neutral restatement:] percentage of [added by the neutral restatement:] body weight was associated with lower all-cause mortality, with roughly 23% [added by the neutral restatement:] lower risk per 10-percentage-point increment in that ratio.
Red-tinted words in the claim drifted from the evidence. Green-tinted words are what a neutral restatement needs.
The trace / claim to source
- A real study from Japan exists, published in a mainstream peer-reviewed journal (The American Journal of Medicine, 2015).
- The 23% figure is not invented. It is the authors' own phrasing for all-cause mortality.
- The exposure was genuinely quadriceps strength expressed relative to body weight.
- The increment genuinely was "10%" of body weight in the strength-to-weight ratio.
- The association survived adjustment for several prognostic variables and was statistically robust (95% CI 0.67-0.89).
- Population generalization (subgroup generalization): the claim says "a person's" risk. The study enrolled only patients hospitalized with coronary artery disease after acute coronary syndrome or bypass surgery, average age 65, 80% male. It does not establish this figure for healthy adults, women specifically, or younger people.
- Implied causal and modifiable effect (unsupported causal inference): "for every 10% increase in quadriceps strength ... risk dropped by 23%" reads as though gaining strength produces that benefit. The study compared different people measured once at baseline. It did not test whether increasing strength changes mortality, and no strength-training intervention was involved.
- Unit ambiguity that inflates the apparent ease of the gain: the study's increment is 10 percentage points of the strength-to-body-weight ratio, not a 10% relative improvement in strength. For a patient at 45% BW, reaching 55% BW is roughly a 22% relative strength gain, not 10%. A casual reader will substantially underestimate what "10%" means here.
- Absolute vs relative risk (exaggeration by omission): 23% is a relative hazard reduction. With 118 deaths among 1314 patients over five years, the absolute difference is far smaller than "23%" sounds.
- Omitted qualifier on residual confounding: quadriceps strength in cardiac patients partly reflects underlying disease severity, frailty, deconditioning and comorbidity. The all-cause model adjusted for a limited covariate set (age, BMI, prior heart failure, prior stroke/TIA), so reverse causation and confounding cannot be excluded.
- I could not confirm the Instagram post's exact on-screen wording or whether it named the study, since the post itself was not retrievable. The investigation is based on the claim text as supplied.
- Whether the creator intended this specific 2015 Kamiya study cannot be proven, though the 23% all-cause figure plus the "10% relative to body weight" framing plus "Japan" match it exactly and I found no other Japanese study producing that combination.
- Whether the same 23% magnitude would hold in a healthy general population is not established by this paper. Broader cohorts such as Health ABC also link low quadriceps strength to higher mortality, but using different units. In that US cohort of adults aged 70-79, per standard deviation of quadriceps strength the crude hazard ratio was 1.51 for men and 1.65 for women , which is a different metric and not interchangeable with the Japanese figure.
- Full-text limitations section was not directly retrieved, so the authors' own stated caveats are only partially documented here.
The 23% figure is real and traces to a genuine Japanese study. The stated purpose was to investigate the prognostic value of quadriceps isometric strength (QIS) in coronary artery disease (CAD) . The study population consisted of 1314 patients aged over 30 years (mean 64.7 ± 10.6 years, 1051 male) with CAD who were hospitalized for acute coronary syndrome or coronary artery bypass grafting; maximal QIS was evaluated as a marker of leg strength and expressed relative to body weight (% body weight), with all-cause death as the primary endpoint and cardiovascular death as the secondary endpoint . During a mean follow-up of 5.0 ± 3.5 years, corresponding to 6537 person-years, there were 118 all-cause deaths and 63 CV deaths, and higher QIS remained associated with decreased all-cause and CV mortality risk (hazard ratio for each increasing 10% body weight of QIS 0.77, 95% CI 0.67-0.89) . The authors' own summary states: each 10% BW increase of maximal QIS is associated with reductions of 23% and 34% in risks of all-cause and CV mortality, respectively, even after adjustment for several independent variables . The paper concluded that a high level of quadriceps strength was strongly associated with lower risks of all-cause and CV mortality in patients with CAD, and that QIS provided incremental prognostic information .
Complete reasoning
The reply receipt is formatted for pasting into the thread where the claim is circulating.
Compact share page: verify.trueseeker.com/s/23021bd2711e/TXdNT4gj0M4mQCuNEfIxRJE
Ask this case
Answers come only from the case file above; nothing is added.
Is the 23% statistic made up?
No. It comes from a real 2015 study in The American Journal of Medicine, and 23% is the authors' own figure for reduced all-cause mortality risk.
Does this mean if I get 10% stronger legs, I lower my death risk by 23%?
Not according to this study. It compared different people measured once, so it does not show that gaining strength causes a lower risk, and no strength training was tested.
Who was actually studied?
The study followed 1,314 patients hospitalized for coronary artery disease in Japan, averaging 65 years old and 80% male. It does not establish this result for healthy adults, younger people, or women specifically.
What does the '10% increase' really refer to?
It means a 10 percentage point increase in quadriceps strength measured as a share of body weight, not a 10% relative improvement in strength. This is a much bigger and less intuitive change than it sounds.
Could something else explain the link between weak legs and higher death risk?
Possibly. Weaker legs in heart disease patients can reflect more advanced illness, frailty, or other health problems, and the study's adjustments do not rule this out.